Insight Molecular Diagnostics Inc. Diluted Shares Outstanding (Weighted Average)
Insight Molecular Diagnostics Inc. (IMDX) reported Diluted Shares Outstanding (Weighted Average) of 36.75 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 36.75M shares, a 14.76% increase year-over-year.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 34.52M shares, a 34.35% increase year-over-year.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 32.08M shares, a 84.26% increase year-over-year.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 32.03M shares, a 133.58% increase year-over-year.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 30.48M shares, a 133.16% increase from fiscal 2024.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 13.07M shares, a 70.84% increase from fiscal 2023.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 7.65M shares, a 38.10% increase from fiscal 2022.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 5.54M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 36.75M shares 10-Q · filed 2026-08-10 | 35.64M shares 10-Q · filed 2026-08-10 | 34.45M shares derived: average of 3 quarters · filed 2026-08-10 | 33.85M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | 34.52M shares 10-Q · filed 2026-05-13 | 33.30M shares derived: average of 2 quarters · filed 2026-05-13 | 32.88M shares derived: average of 3 quarters · filed 2026-05-13 | 32.66M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | 32.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 32.06M shares derived: average of 2 quarters · filed 2026-03-26 | 32.05M shares derived: average of 3 quarters · filed 2026-08-10 | 30.48M shares 10-K · filed 2026-03-26 | |||
| 2025-09-30 | 32.03M shares 10-Q · filed 2025-11-10 | 32.03M shares derived: average of 2 quarters · filed 2026-08-10 | 29.94M shares 10-Q · filed 2025-11-10 | 26.79M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2025-06-30 | 32.02M shares 10-Q · filed 2026-08-10 | 28.88M shares 10-Q · filed 2026-08-10 | 25.04M shares derived: average of 3 quarters · filed 2026-08-10 | 22.21M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | 25.69M shares 10-Q · filed 2026-05-13 | 21.55M shares derived: average of 2 quarters · filed 2026-05-13 | 18.94M shares derived: average of 3 quarters · filed 2026-05-13 | 17.42M shares derived: average of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | 17.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 15.56M shares derived: average of 2 quarters · filed 2026-03-26 | 14.67M shares derived: average of 3 quarters · filed 2026-03-26 | 13.07M shares 10-K · filed 2026-03-26 | |||
| 2024-09-30 | 13.71M shares 10-Q · filed 2025-11-10 | 13.29M shares derived: average of 2 quarters · filed 2025-11-10 | 11.62M shares 10-Q · filed 2025-11-10 | 10.78M shares derived: average of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | 12.87M shares 10-Q · filed 2025-08-11 | 10.57M shares 10-Q · filed 2025-08-11 | 9.80M shares derived: average of 3 quarters · filed 2025-08-11 | 9.41M shares derived: average of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | 8.26M shares 10-Q · filed 2025-05-12 | 8.27M shares derived: average of 2 quarters · filed 2025-05-12 | 8.26M shares derived: average of 3 quarters · filed 2025-05-12 | 8.22M shares derived: average of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | 8.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 8.26M shares derived: average of 2 quarters · filed 2025-03-24 | 8.20M shares derived: average of 3 quarters · filed 2025-03-24 | 7.65M shares 10-K · filed 2025-03-24 | |||
| 2023-09-30 | 8.26M shares 10-Q · filed 2024-11-12 | 8.26K shares 10-Q · filed 2023-11-09 | 8.17M shares derived: average of 2 quarters · filed 2024-11-12 | 7.45M shares 10-Q · filed 2024-11-12 | 7.45K shares 10-Q · filed 2023-11-09 | 11.11M shares derived: average of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | 8.09M shares 10-Q · filed 2024-08-08 | 8.09K shares 10-Q · filed 2023-08-10 | 7.03M shares 10-Q · filed 2024-08-08 | 7.03K shares 10-Q · filed 2023-08-10 | 12.07M shares derived: average of 3 quarters · filed 2024-08-08 | 9.05M shares derived: average of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | 5.96M shares 10-Q · filed 2024-05-15 | 119.25M shares 10-Q · filed 2023-05-15 | 14.05M shares derived: average of 2 quarters · filed 2024-05-15 | 9.37M shares derived: average of 3 quarters · filed 2024-05-15 | 7.03M shares derived: average of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | 22.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 11.07M shares derived: average of 2 quarters · filed 2024-04-16 | 7.39M shares derived: average of 3 quarters · filed 2024-04-16 | 5.54M shares 10-K · filed 2024-04-16 | |||
| 2022-09-30 | 5.93K shares 10-Q · filed 2023-11-09 | 5.79K shares derived: average of 2 quarters · filed 2023-11-09 | 5.41K shares 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | 5.65K shares 10-Q · filed 2023-08-10 | 5.13K shares 10-Q · filed 2023-08-10 | |||||
| 2022-03-31 | 92.24M shares 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |